Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Olaparib in Recurrent Breast and Ovarian Cancer
NCT00679783Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2008
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of olaparib in breast cancer, ovarian cancer, sponsored by AstraZeneca. Started Jul 2008; status: completed.
02
Drugs
olaparib
03
Conditions
breast cancerovarian cancer
Beyond the preview
Go deeper on NCT00679783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679783.